Compound or practice · Supplement

Quercetin

A flavonoid with modest blood-pressure data, a senolytic research role, and poor absorption to overcome.

Overall grade
Grade C
Last revised
2
graded outcomes
0
references listed

A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.

1 at grade C · 1 at grade D — 2 graded rows

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Blood pressureEvidence grade C

    Higher doses

    Smallmixed

  • Senolytic (healthspan)Evidence grade D

    Experimental, drug-paired

    Unclearlow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Blood pressure (grade C); Senolytic (healthspan) (grade D).
  • Caution with Blood-pressure medications: Additive blood-pressure lowering.

Interactions

Documented pairings with supplements and medicines. A medicine on this list is a conversation for whoever prescribes it.

  • Blood-pressure medicationsCaution

    Additive blood-pressure lowering.

The evidence in words

What it is

Quercetin is a plant flavonoid found in onions and apples, studied for blood pressure, allergy, and (with fisetin) as a senolytic.

How it works

It has antioxidant, anti-inflammatory, and antihistamine actions, and in senolytic research clears senescent cells (usually paired with dasatinib in trials).

What the evidence shows

Meta-analyses show a modest blood-pressure reduction, especially at higher doses; allergy and exercise data are weaker. Its senolytic use is experimental and drug-paired. Bioavailability is poor, so formulation matters.

How to use it

500–1,000 mg/day (with absorption enhancers) for blood pressure.

Safety & interactions

Generally safe; high doses may affect kidney and drug metabolism (CYP inhibition). antihypertensives — Additive blood-pressure lowering.

Bottom line

A modest blood-pressure helper with an experimental senolytic sideline. Real but minor; absorption is the bottleneck.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
500–1,000 mg/day, absorption-enhanced.

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own.

Last revised . A grade is this entry's reading of the evidence, not medical advice.